openPR Logo
Press release

Prader-Willi Syndrome Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | Novo Nordisk, Pfizer, Sandoz, Harmony Biosciences, Soleno Therapeutics, Harmony Biosciences

10-22-2024 04:14 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Prader-Willi Syndrome Market Forecasted to Surge in Coming

DelveInsight's "Prader-Willi Syndrome Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Prader-Willi Syndrome, historical and forecasted epidemiology as well as the Prader-Willi Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Prader-Willi Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Prader-Willi Syndrome Market Forecast [https://www.delveinsight.com/sample-request/prader-willi-syndrome-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Some of the key facts of the Prader-Willi Syndrome Market Report:

*
The Prader-Willi Syndrome market size is anticipated to grow with a significant CAGR during the study period (2020-2034)

*
The overall market size for PWS in the US was projected to be approximately USD 500 million in 2023, with expectations for growth throughout the forecast period (2024-2034).

*
In EU4 and the UK, Germany held the largest market share, with a market size of approximately USD 30 million in 2023, and this is anticipated to increase during the forecast period (2024-2034).

*
There is significant uncertainty regarding the therapies from Gedeon Richter and Palobiofarma due to a lack of substantial evidence on their safety and efficacy. In contrast, Palobiofarma's PBF-999 is anticipated to be launched first in Spain.

*
In 2023, the US had the highest number of prevalent cases of PWS among the 7MM, totaling approximately 22,600 cases, which are projected to rise during the forecast period.

*
In 2023, Germany had the highest number of total prevalent cases of PWS among the EU4 and the UK, whereas Spain recorded the lowest number of cases.

*
Estimates indicate that in Japan, PWS was most commonly seen in the 18-40 age group, representing over 38% of all cases in 2023.

*
In 2023, within the United States, the paternal microdeletion subtype represented the largest share of genetic subtype-specific cases of PWS, comprising around 70% of cases, while the translocation subtype was the least prevalent.

*
Key Prader-Willi Syndrome Companies: Novo Nordisk, Pfizer, Sandoz, Harmony Biosciences, Soleno Therapeutics, Harmony Biosciences, ACADIA Pharmaceuticals, Aardvark Therapeutics, Gedeon Richter, Palobiofarma, ConSynance Therapeutics, and others

*
Key Prader-Willi Syndrome Therapies: NORDITROPIN, GENOTROPIN, OMNITROPE, WAKIX (pitolisant), Diazoxide Choline Controlled-Release (DCCR), WAKIX (pitolisant), DCCR (diazoxide choline), Carbetocin (LV-101), ARD-101, RGH-706, PBF-999, CSTI-500, and others

*
The Prader-Willi Syndrome market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Prader-Willi Syndrome pipeline products will significantly revolutionize the Prader-Willi Syndrome market dynamics.

Prader-Willi Syndrome Overview

Prader-Willi Syndrome (PWS) is a complex genetic disorder that affects many parts of the body. The condition is characterized by weak muscle tone (hypotonia) and feeding difficulties in infancy, followed by excessive eating and gradual development of obesity. Individuals with Prader-Willi Syndrome typically have intellectual disability, behavioral problems, and distinctive physical features such as almond-shaped eyes, a narrowing of the head at the temples, and a turned-down mouth.

Get a Free sample for the Prader-Willi Syndrome Market Forecast, Size & Share Analysis Report:

https://www.delveinsight.com/report-store/prader-willi-syndrome-market [https://www.delveinsight.com/report-store/prader-willi-syndrome-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Prader-Willi Syndrome Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Prader-Willi Syndrome Epidemiology Segmentation:

The Prader-Willi Syndrome market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:

*
Total Prevalence of Prader-Willi Syndrome

*
Prevalent Cases of Prader-Willi Syndrome by severity

*
Gender-specific Prevalence of Prader-Willi Syndrome

*
Diagnosed Cases of Episodic and Chronic Prader-Willi Syndrome

Download the report to understand which factors are driving Prader-Willi Syndrome epidemiology trends @ Prader-Willi Syndrome Epidemiology Forecast [https://www.delveinsight.com/sample-request/prader-willi-syndrome-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Prader-Willi Syndrome Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Prader-Willi Syndrome market or expected to get launched during the study period. The analysis covers Prader-Willi Syndrome market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Prader-Willi Syndrome Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Prader-Willi Syndrome Therapies and Key Companies

*
NORDITROPIN: Novo Nordisk

*
GENOTROPIN: Pfizer

*
OMNITROPE: Sandoz

*
WAKIX (pitolisant): Harmony Biosciences

*
Diazoxide Choline Controlled-Release (DCCR): Soleno Therapeutics

*
WAKIX (pitolisant): Harmony Biosciences

*
DCCR (diazoxide choline): Soleno Therapeutics

*
Carbetocin (LV-101): ACADIA Pharmaceuticals

*
ARD-101: Aardvark Therapeutics

*
RGH-706: Gedeon Richter

*
PBF-999: Palobiofarma

*
CSTI-500: ConSynance Therapeutics

Discover more about therapies set to grab major Prader-Willi Syndrome market share @ Prader-Willi Syndrome Treatment Landscape [https://www.delveinsight.com/sample-request/prader-willi-syndrome-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Scope of the Prader-Willi Syndrome Market Report

*
Study Period: 2020-2034

*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

*
Key Prader-Willi Syndrome Companies: Novo Nordisk, Pfizer, Sandoz, Harmony Biosciences, Soleno Therapeutics, Harmony Biosciences, ACADIA Pharmaceuticals, Aardvark Therapeutics, Gedeon Richter, Palobiofarma, ConSynance Therapeutics, and others

*
Key Prader-Willi Syndrome Therapies: NORDITROPIN, GENOTROPIN, OMNITROPE, WAKIX (pitolisant), Diazoxide Choline Controlled-Release (DCCR), WAKIX (pitolisant), DCCR (diazoxide choline), Carbetocin (LV-101), ARD-101, RGH-706, PBF-999, CSTI-500, and others

*
Prader-Willi Syndrome Therapeutic Assessment: Prader-Willi Syndrome current marketed and Prader-Willi Syndrome emerging therapies

*
Prader-Willi Syndrome Market Dynamics: Prader-Willi Syndrome market drivers and Prader-Willi Syndrome market barriers

*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies

*
Prader-Willi Syndrome Unmet Needs, KOL's views, Analyst's views, Prader-Willi Syndrome Market Access and Reimbursement

To know more about Prader-Willi Syndrome companies working in the treatment market, visit @ Prader-Willi Syndrome Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/prader-willi-syndrome-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Table of Contents

1. Prader-Willi Syndrome Market Report Introduction

2. Executive Summary for Prader-Willi Syndrome

3. SWOT analysis of Prader-Willi Syndrome

4. Prader-Willi Syndrome Patient Share (%) Overview at a Glance

5. Prader-Willi Syndrome Market Overview at a Glance

6. Prader-Willi Syndrome Disease Background and Overview

7. Prader-Willi Syndrome Epidemiology and Patient Population

8. Country-Specific Patient Population of Prader-Willi Syndrome

9. Prader-Willi Syndrome Current Treatment and Medical Practices

10. Prader-Willi Syndrome Unmet Needs

11. Prader-Willi Syndrome Emerging Therapies

12. Prader-Willi Syndrome Market Outlook

13. Country-Wise Prader-Willi Syndrome Market Analysis (2020-2034)

14. Prader-Willi Syndrome Market Access and Reimbursement of Therapies

15. Prader-Willi Syndrome Market Drivers

16. Prader-Willi Syndrome Market Barriers

17. Prader-Willi Syndrome Appendix

18. Prader-Willi Syndrome Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=praderwilli-syndrome-market-forecasted-to-surge-in-coming-years-20242034-analysis-by-delveinsight-novo-nordisk-pfizer-sandoz-harmony-biosciences-soleno-therapeutics-harmony-biosciences]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Prader-Willi Syndrome Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | Novo Nordisk, Pfizer, Sandoz, Harmony Biosciences, Soleno Therapeutics, Harmony Biosciences here

News-ID: 3704897 • Views:

More Releases from ABNewswire

FiscalExpat.com Launches as Premier International Tax Intelligence Platform
FiscalExpat.com Launches as Premier International Tax Intelligence Platform
Wyoming-Based Digital Publication Aims to Become Definitive Authority on Cross-Border Taxation Cheyenne, Wyoming - Sep 30, 2025 - International taxation has never been more complex, and reliable guidance has never been harder to find. FiscalExpat.com (https://fiscalexpat.com [https://fiscalexpat.com/]) launches today as a comprehensive digital resource dedicated to helping expatriates, remote workers, and international professionals navigate the intricate world of cross-border tax compliance. The platform addresses a critical gap in the market: the lack
New Jersey Dentist Dr. Lee of Inspo Dental in Red Bank Offers Free Dental Care for First Responders and Veterans on November 19th, 2025
New Jersey Dentist Dr. Lee of Inspo Dental in Red Bank Offers Free Dental Care f …
Red Bank, NJ - Sep 30, 2025 - Inspo Dental, a leading New Jersey dental office in Red Bank, is giving back to the community with a special event dedicated to local heroes. On Wednesday, November 19th, 2025, Inspo Dental will host "For the Brave, From the Heart" -a free day of dentistry in New Jersey [https://www.inspodental.com/] for first responders and veterans, including police officers, firefighters, EMS, corrections officers, dispatchers,
Tampa Attorney Offers Free Seminar to Help Families Avoid the Chaos of Planning Too Late.
Tampa Attorney Offers Free Seminar to Help Families Avoid the Chaos of Planning …
The Faulkner Firm today announced a free community seminar aimed at helping Tampa-area families secure their futures and avoid the emotional and financial burden of unplanned estates. Titled "Don't Leave a Mess. Leave a Legacy," the event is a direct response to the staggering statistic that nearly half of all American adults lack basic estate planning documents. Hosted by firm founder and attorney Debbie Faulkner, the workshop will provide a compassionate,
Confidencias del corazon by Carlos Mavila: A Poetic Tribute to Love, Memory, and the Feminine Soul
Confidencias del corazon by Carlos Mavila: A Poetic Tribute to Love, Memory, and …
At a time when poetry is regaining its voice as a space of intimacy and reflection, Latin American poet Carlos Mavila V. A. presents Confidencias del corazon , the second volume of his Alma Poetica series. Now available worldwide on Amazon [https://www.amazon.com/Confidencias-coraz%C3%B3n-Alma-po%C3%A9tica-Spanish-ebook/dp/B0FMPNBM89/?utm_source=chatgpt.com], this book gathers seventy-six poems written across decades, a lyrical mosaic that portrays love in its many transformations-from passion to silence, absence to reconciliation, illusion to maturity. A Journey

All 5 Releases


More Releases for Syndrome

"Understanding Rett Syndrome: Trends and Advances in the Rett Syndrome Market"
The Rett Syndrome Market, valued at USD 225.02 million in 2022, is anticipated to surge to USD 515.06 million by 2029, reflecting a significant Compound Annual Growth Rate (CAGR) of 10.23% from 2023 to 2029. Overview of the Rett Syndrome Market: Rett syndrome, a rare genetic neurological and developmental disorder primarily impacting females, hinders brain development and causes progressive loss of motor skills and language. The market report underscores technological advancements
MISME Syndrome Market - Navigating Challenges, Embracing Abilities: MISME Syndro …
Newark, New Castle, USA: The "MISME Syndrome Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. MISME Syndrome Market: https://www.growthplusreports.com/report/misme-syndrome-market/8883 This latest report researches the industry structure, sales, revenue,
Felty Syndrome Market - A Dedicated Approach to Felty Syndrome Care and Empowerm …
Newark, New Castle, USA: The "Felty Syndrome Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Felty Syndrome Market: https://www.growthplusreports.com/report/felty-syndrome-market/8440 This latest report researches the industry structure, sales, revenue,
MISME Syndrome Market - Transforming Lives: Empowering Recovery from MISME Syndr …
Newark, New Castle, USA - new report, titled MISME Syndrome Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the MISME Syndrome market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global MISME Syndrome market. The report offers an overview of the market, which
Hepatorenal Syndrome Market - Reimagining Wellness, Redefining Survival: Hepator …
Newark, New Castle, USA - new report, titled Hepatorenal Syndrome Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Hepatorenal Syndrome market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Hepatorenal Syndrome market. The report offers an overview of the market, which
Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syn …
Global Markets Directs, Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H2 2016, provides an overview of the Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and